Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.27
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.27
CLLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

11 Apr 2013 12:02

RNS Number : 1334C
Carillion PLC
11 April 2013
 

Carillion plc

(the "Company")

 

Deferred Bonus Plan (the "Plan") Vesting of Shares

 

Carillion plc announces the following changes in the interests of PDMRs in the ordinary shares of 50 pence each (the "Shares") in the Company.

 

Shares were transferred under the Plan on 10 April 2013 to PDMRs as set out below. In accordance with the Plan rules, the shares were held in trust for up to two years before being transferred.

 

No. of Ordinary Shares of 50p each vesting

No. of Ordinary Shares of 50p each sold on 10 April 2013 at £2.826935

Richard Howson, Group Chief Executive

12,560

-

Richard Adam, Group Finance Director

13,310

13,310

Simon Buttery, MD Carillion Canada

8,244

-

Shaun Carter, Group Development and Strategy Director

7,638

-

Adam Green, MD Carillion UK Construction

21,028

21,028

John Platt, MD Carillion Facilities Management

16,847

16,847

Richard Tapp, Company Secretary

23,451

23,451

Nigel Taylor, Chief Operating Officer, Carillion Services

8,488

4,010

Simon Webb, MD Al Futtaim Carillion JV

8,147

-

 

All of the above PDMRs (except Messrs. Buttery, Carter, Howson and Webb- see below) sold the shares received under the Plan on 10 April 2013 at a price of £2.826935 per share in order, inter alia, to realise sufficient funds to settle resultant UK tax and social security liabilities arising from the transfer.

 

Messrs. Buttery, Carter, Howson and Webb were/ are not tax resident in the UK when the shares were awarded under the Plan.

 

The total number of Carillion shares in which each of these PDMRs has an interest following these transactions are as follows:

 

Total No. of Ordinary Shares

of 50p each*

Richard Howson, Group Chief Executive

80,132

Richard Adam, Group Finance Director

157,004

Simon Buttery, MD Carillion Canada

8,244

Shaun Carter, Group Development and Strategy Director

22,059

Adam Green, MD Carillion UK Construction

13,009

John Platt, MD Carillion Facilities Management

5,702

Richard Tapp, Company Secretary

150,653

Nigel Taylor, Chief Operating Officer, Carillion Services

4,478

Simon Webb, MD Al Futtaim Carillion JV

14,460

 

 

*Each holding less than 0.04% of the issued share capital.

 

Tim George

Deputy Company Secretary

Carillion plc

11 April 2013

Tel: 01902 422431

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAFLFFEEDEFF
Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.